These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1482945)

  • 1. Computer-focused modification of physician prescribing behavior.
    Zieve FJ; Ciesco E
    Proc Annu Symp Comput Appl Med Care; 1992; ():617-20. PubMed ID: 1482945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing outpatient costs of nonsteroidal antiinflammatory drugs at a Department of Veterans Affairs teaching hospital.
    Drexler PG; Lambdin CS
    J Pharm Technol; 1993; 9(1):10-3. PubMed ID: 10123760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating prescribing interventions.
    Wong G
    Br J Gen Pract; 2002 May; 52(478):412-3. PubMed ID: 12014546
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining product risk in context. Market withdrawal of zomepirac as a case study.
    Ross-Degnan D; Soumerai SB; Fortess EE; Gurwitz JH
    JAMA; 1993 Oct; 270(16):1937-42. PubMed ID: 8411550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.
    Abrams TE; Lund BC; Bernardy NC; Friedman MJ
    Psychiatr Serv; 2013 Feb; 64(2):142-8. PubMed ID: 23474508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' outreach visits and doctors' prescribing.
    Henry DA; Robertson J
    Med J Aust; 1999 May; 170(10):460-1. PubMed ID: 10376017
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing physician prescribing behavior: a low-cost administrative policy that reduced the use of brand name nonsteroidal anti-inflammatory drugs.
    Ahluwalia JS; Weisenberger ML; Bernard AM; McNagny SE
    Prev Med; 1996; 25(6):668-72. PubMed ID: 8936568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' antibiotic prescribing behavior in Taiwan, 1998-2011.
    Iqbal U; Syed-Abdul S; Nguyen PA; Jian WS; Li YC
    Clin Infect Dis; 2015 May; 60(9):1439-41. PubMed ID: 25605281
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of pharmacoeconomic factors on prescribing patterns in Ireland.
    Feely J
    Pharmacoeconomics; 1992 Aug; 2(2):99-106. PubMed ID: 10146950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Legal format and costs of prescriptions at the Central Hospital in Yaounde, Cameroon].
    Blatt A; Chambon R; Lemardeley P
    Med Trop (Mars); 1997; 57(1):37-40. PubMed ID: 9289607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance between psychotropic prescribing for veterans with PTSD and clinical practice guidelines.
    Jain S; Greenbaum MA; Rosen C
    Psychiatr Serv; 2012 Feb; 63(2):154-60. PubMed ID: 22302333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.
    Tuchscherer RM; Nair K; Ghushchyan V; Saseen JJ
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):27-34. PubMed ID: 25348907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do clinical grant payment practices in phase 3 clinical trials influence subsequent clinical investigator prescribing behavior?
    Glass HE
    Dis Manag; 2004; 7(1):77-87. PubMed ID: 15035835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial investigators and their prescribing patterns: another dimension to the relationship between physician investigators and the pharmaceutical industry.
    Psaty BM; Rennie D
    JAMA; 2006 Jun; 295(23):2787-90. PubMed ID: 16788134
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic constraints and prescribing patterns in New Zealand.
    Kellaway GS
    Pharmacoeconomics; 1992 Sep; 2(3):189-97. PubMed ID: 10147009
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving the quality and cost-effectiveness of prescribing.
    Avorn J
    Pharmacoeconomics; 1992; 1(Suppl 1):45-8. PubMed ID: 10146931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating drug prescribing in a large, ambulatory population: application of an embedded expert system.
    Speedie SM; McNally D; Skarupa S; Michocki R; Rudo C; Metge C; Palumbo F; Knapp D
    Proc Annu Symp Comput Appl Med Care; 1992; ():621-5. PubMed ID: 1482946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.